Neumora Therapeutics, Inc. (NMRA)
2.64
-0.19
(-6.71%)
USD |
NASDAQ |
Mar 18, 16:00
2.635
0.00 (0.00%)
After-Hours: 20:00
Neumora Therapeutics Market Cap : 441.12M for March 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 819.81B |
| Protalix Biotherapeutics, Inc. | 177.73M |
| Nautilus Biotechnology, Inc. | 346.79M |
| Ventyx Biosciences, Inc. (DELISTED) | 999.02M |
| ProKidney Corp. | 294.41M |
Market Cap Related Metrics
| Price to Book Value | 3.338 |
| Price | 2.64 |
| Earnings Yield | -55.43% |